Showing 161 - 180 results of 22,481 for search '"immunosuppression"', query time: 0.22s Refine Results
  1. 161
  2. 162

    The (Sialyl) Tn antigen: Contributions to immunosuppression in gastrointestinal cancers by Christabelle Rajesh, Prakash Radhakrishnan

    Published 2023-01-01
    “…Studying the interaction between Tn/STn antigens and the TIME of gastrointestinal cancers can help develop better and more robust therapies that can counteract immunosuppressive mechanisms to sensitize these tumors to anticancer therapies.…”
    Get full text
    Article
  3. 163

    Systemic and local immunosuppression in glioblastoma and its prognostic significance by Aleksei A. Stepanenko, Aleksei A. Stepanenko, Anastasiia O. Sosnovtseva, Anastasiia O. Sosnovtseva, Marat P. Valikhov, Marat P. Valikhov, Anastasia A. Chernysheva, Olga V. Abramova, Konstantin A. Pavlov, Vladimir P. Chekhonin, Vladimir P. Chekhonin

    Published 2024-02-01
    “…However, various local and systemic mechanisms of immunosuppression operate in cancer patients. Tumor-associated immunosuppression involves deregulation of many components of immunity, including a decrease in the number of T lymphocytes (lymphopenia), an increase in the levels or ratios of circulating and tumor-infiltrating immunosuppressive subsets [e.g., macrophages, microglia, myeloid-derived suppressor cells (MDSCs), and regulatory T cells (Tregs)], as well as defective functions of subsets of antigen-presenting, helper and effector immune cell due to altered expression of various soluble and membrane proteins (receptors, costimulatory molecules, and cytokines). …”
    Get full text
    Article
  4. 164

    COVID-19 in Immunosuppressed and Cancer Patients: A review by Shirin Haghighat, Mehdi Dehghani

    Published 2020-07-01
    Subjects: “…covid-19, cancer, immunosuppression…”
    Get full text
    Article
  5. 165
  6. 166
  7. 167

    CD200 promotes immunosuppression in the pancreatic tumor microenvironment by Reena Shakya, Mary Dillhoff, Brooke Benner, Thomas A Mace, Terence M Williams, Fouad Choueiry, Molly Torok, Kriti Agrawal, Anna Deems, Alice Hinton, Jami Shaffer, Bradley W Blaser, Anne M Noonan, Darwin L Conwell, Phil A Hart, Zobeida Cruz-Monserrate, Xue-Feng Bai, William E Carson III

    Published 2020-05-01
    “…Background A significant challenge to overcome in pancreatic ductal adenocarcinoma (PDAC) is the profound systemic immunosuppression that renders this disease non-responsive to immunotherapy. …”
    Get full text
    Article
  8. 168
  9. 169
  10. 170
  11. 171
  12. 172
  13. 173
  14. 174
  15. 175
  16. 176
  17. 177

    Viewpoint about biologic agents for psoriasis: are they immunosuppressants or immunomodulators? by Dea Metko, Tiago Torres, Ronald Vender

    Published 2023-06-01
    “…One of the most challenging components of marketing and prescribing these biologic therapies has been in classifying them as immunomodulators or immunosuppressants. The purpose of this narrative review was to discuss the features that distinguish immunomodulators from immunosuppressants to successfully categorize the biologic therapies used for psoriasis management and subsequently enhance patient and physician understanding of the risks associated with the use of these drugs.…”
    Get full text
    Article
  18. 178
  19. 179

    Hypoxia-mediated repression of pyruvate carboxylase drives immunosuppression by Michael F. Coleman, Eylem Kulkoyluoglu Cotul, Alexander J. Pfeil, Emily N. Devericks, Muhammad H. Safdar, Marvis Monteiro, Hao Chen, Alyssa N. Ho, Numair Attaar, Hannah M. Malian, Violet A. Kiesel, Alexis Ramos, Matthew Smith, Heena Panchal, Adam Mailloux, Dorothy Teegarden, Stephen D. Hursting, Michael K. Wendt

    Published 2024-06-01
    “…We identify hypoxia-mediated suppression of pyruvate carboxylase (PC), and subsequent induction of lactate production, as a metabolic regulator of immunosuppression. Methods We used qPCR, immunoblot, and reporter assays to characterize repression of PC in hypoxic primary tumors. …”
    Get full text
    Article
  20. 180

    Cutaneous Coinfection of Cytomegalovirus and Mycobacterium chelonae Accelerated by Immunosuppression by Yutaka Tsutsumi, Kentaro Odani, Yasuhito Kaneko, Hideo Hashizume, Mitsuhiro Tachibana

    Published 2021-01-01
    “…Pyoderma gangrenosum was clinically diagnosed after the first biopsy, indicating a noninfective ulcer. Immunosuppressive therapy (prednisolone and cyclosporine A) induced complete epithelialization in three months. …”
    Get full text
    Article